Researchers and scientists in Greece have been testing a possible new treatment for the asbestos related cancer mesothelioma. The standard treatments used in chemotherapy for the treatment of mesothelioma is cisplatin and pemetrexed or in some cases a combination of cisplatin and gemcitabine.
However, since it has not been tried before researchers from the Athens University School of Medicine in Greece are testing the effectiveness of gemcitabine plus docetaxel as a chemotherapy option for mesothelioma patients, and the aim is to see whether it will be more or less effective than the standard treatments outlined above.
Twenty five patients that suffered from malignant pleural mesothelioma were enrolled as part of the trial into this combination treatment. The treatment was administered on the first and fourteenth day of a twenty eight day cycle, and was scheduled for six months or until the cancer spread.
The results showed that twenty eight percent of patients, equating to seven out of the twenty five, responded to the treatment. The tumors of these seven patients were shown to have shrunk in size. Fir fourteen of the patients there was no change in tumor size. However, for the remaining four the tumors actually increased in size.